SpaceX is preparing for an IPO.

The planned offering has been reported at about 556 million shares at USD 135 per share, raising roughly USD 75 billion and implying a valuation around USD 1.75 trillion. If completed, it would be one of the largest IPOs in global capital-market history.

For investors in Mainland China and Hong Kong, the most important detail may be something else.

Bloomberg reported on June 5 that lead underwriters for the SpaceX IPO had asked syndicate members not to accept subscription orders from clients in Mainland China and Hong Kong, including private-banking clients. Reuters later cited the report and clearly stated it could not independently confirm the restriction.

So the careful wording is this: as of writing, the SpaceX underwriting process was reportedly applying subscription restrictions to Mainland China and Hong Kong clients.

Even with that qualification, the trend is worth studying. The world's rarest assets are moving from "if you have money, you can buy" toward "first, check whether you are allowed in."

This Is Not an Ordinary Technology Stock

If SpaceX were only a commercial rocket company, the issue would attract less attention.

SpaceX spans rocket launches, human spaceflight, low-earth-orbit satellite communications, and government projects. Falcon rockets serve commercial and government launches. Dragon supports human spaceflight. Starlink is building a global satellite-communications network.

These businesses have commercial value, but they also relate to national security, communications resilience, and space infrastructure.

Once a company combines launch capability, orbital networks, communications access, and government contracts, its shares are no longer ordinary financial assets. Whether investors can view offering materials, submit orders, or enter the shareholder list may be subject to stricter compliance frameworks.

Bloomberg cited regulatory and compliance concerns but did not disclose a complete legal basis. Reuters also noted that SpaceX's website and IPO marketing materials were reportedly inaccessible in Mainland China and Hong Kong at the time.

This is consistent with a broader US trend of expanding sensitive-technology and national-security review. In the past, the focus was chips, equipment, software, and technology exports. Now the boundary may extend further into capital markets: who can read materials, place orders, and become a shareholder of a strategic technology company.

Why Hong Kong's Inclusion Matters

It is not new that Mainland Chinese investors may face limits in directly participating in some US IPOs. The more striking part of the report is that Hong Kong clients were also included.

Hong Kong has long been an international financial center and a key channel for Mainland high-net-worth clients to allocate global assets. Private banks, international brokers, and offshore accounts have allowed Hong Kong clients to access US-listed companies, international funds, and popular IPOs.

But with a sensitive asset such as SpaceX, banks will look not only at account type. They will also consider client identity, source of funds, ultimate beneficial owners, product distribution rules, and jurisdictional risk.

Hong Kong's financial-center status provides market infrastructure. It does not remove geopolitical compliance boundaries.

This means the phrase "global allocation" may need a footnote: not all global assets are equally open to all clients.

The rarer, more strategic, and more technology-sensitive an asset is, the more likely it is to face refined client classification and access screening.

Money Is Not Enough

For the past two decades, global capital markets gave many investors a strong impression: if your account is compliant and you have enough capital, you can share in the growth of the world's best companies.

After listing, companies such as Google, Meta, Tesla, and Nvidia became public assets that investors around the world could trade. Account-opening barriers differed by region, but the market price was broadly shared.

The reported SpaceX restriction changes the issue at the order-eligibility level.

There is no shortage of capital. Star IPOs usually have more demand than allocation. What is scarce is placement quota and permission to enter the distribution list.

This creates a new layering of global asset allocation:

  • ordinary public assets available to most compliant investors;
  • issuance or private opportunities available only to certain regions, account types, or client categories;
  • strategic assets under national-security frameworks, where investor identity is screened more strictly.

Investors used to focus mainly on return, valuation, and liquidity. They now also need to consider access rights.

IPO Restriction Does Not Mean Permanent Trading Ban

A clear boundary is important.

The reports focus on IPO subscription orders. They do not confirm that Mainland China and Hong Kong investors would be unable to trade SpaceX after listing through secondary markets. They also do not mean every fund with Chinese background would be permanently banned from holding the shares.

IPO allocation, secondary-market trading, and indirect fund exposure are different channels. Product rules, broker policies, and compliance reviews may differ.

Until official trading rules, broker notices, and regulatory requirements are clear, it is not rigorous to turn "cannot submit IPO subscription" into "can never buy SpaceX."

But this does not reduce the signal value.

An IPO is the first time a company chooses public-market shareholders. If clients from certain regions cannot even submit orders, investor origin has already become part of transaction design.

What It Means for Hong Kong Investors

First, private-banking access is no longer a guarantee of global access. High-net-worth clients may assume that international private banks can provide access to global hot deals. But before final allocation, underwriters can still tighten order acceptance by region, client category, or risk policy.

Second, investment opportunities now carry stronger policy attributes. Investors must study not only the company, but also whether the sector is sensitive, whether the transaction involves cross-border limits, and whether their own account and identity are acceptable.

Third, alternative exposure becomes more important. If some US strategic technology assets are hard to access directly, capital may look for other routes: post-listing public trading if allowed, supply-chain companies, thematic funds, or domestic companies in commercial space, satellite internet, AI infrastructure, and advanced manufacturing.

But not every company with a space label benefits from SpaceX restrictions. Technical capability, order quality, cash flow, and valuation still need to be evaluated one by one. Turning geopolitical restriction directly into a concept-stock trade is another risk.

Where Is Globalization Going?

Globalization over the past few decades was built on three flows: goods, technology, and capital.

These flows are now diverging. Goods still cross borders. Technology is increasingly bounded by export controls and security reviews. Capital is also more affected by identity, jurisdiction, and industrial attributes.

SpaceX is a very visible sample.

If space launch, satellite communications, and AI infrastructure are strategic assets, similar thresholds may appear in quantum computing, advanced chips, dual-use robotics, cybersecurity, and space computing.

Investors used to compete through insight, capital, and channels. In the future, they may face another question: are the best global assets willing to open to them?

That is the real message behind the reported restriction. It is not only the regret of missing one stock. It is a reminder that capital markets are not naturally borderless. The closer an asset is to the core of technology competition and national security, the less open it may become.

Future asset allocation should not only ask what is best. It should also ask what can be held legally, reliably, and for the long term.

This note is for public-information discussion and macro-financial analysis only. It is not investment advice or a recommendation to buy or subscribe to any security.